comprehensive -WSS

comprehensive

author：focus 2025-09-28 08:13:16 - browse：36

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： NYU Langone launches private ChatGPT for its health care data

knowledge

WSS

How Long Island became the ‘eugenics capital of the world’

Complete sequence of Y chromosome published for first time

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Infant mortality in U.S. rose last year for first time in decades: CDC

Inari Medical to buy amputation prevention company LimFlow

After Sarepta trial failure, Duchenne families brace for more debate

focus

comprehensive

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Activists slam private health insurers over coverage restrictions

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Brain injuries and the importance of a second opinion

New air purifier tech could be key to improving indoor air quality

Sarepta Duchenne therapy fails to meet primary endpoint in trial

BioMarin wins approval for gene therapy to treat hemophilia A

Apellis safety probe of eye disease drug centers on injection needle

focus

After Sarepta trial failure, Duchenne families brace for more debate

What is microchimerism and how does it affect maternal health?

Winners, losers from Medicare’s list of drugs subject to price talks

2024 GOP presidential candidates spar over abortion in debate

FDA panel gives mixed vote on blood pressure devices

Neuroscience startup Neumora files for IPO

focus

knowledge

explore

explore